Clincosm LogoSign in Get a demo

targeted therapy

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Efficacy of Targeted Therapy for NSCLC

Recruiting
  • Evaluation
  • +2 more
  • RecistTM criteria
  • Chongqing, Chongqing, China
    Cancer Center, Dapping Hospital, Army Medical Center of PLA
Nov 15, 2023

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Esophagus Cancer, Esophagogastric Junction Cancer, Chemoradiation Trial in China (Radiotherapy, Platinum based chemo, Paclitaxel

Recruiting
  • Esophagus Cancer
  • +5 more
  • Radiotherapy
  • +5 more
  • Anyang, Henan, China
  • +4 more
Aug 17, 2022

Stage IV NSCLC, Targeted Therapy, Nonsmall Cell Lung Cancer Trial in Boston (POISE)

Not yet recruiting
  • Stage IV Non-small Cell Lung Cancer
  • +7 more
  • POISE
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 13, 2022

Ovarian Carcinoma, Survival Outcomes, Adverse Events Trial in Beijing (Niraparib plus anlotinib)

Recruiting
  • Ovarian Carcinoma
  • +8 more
  • Niraparib plus anlotinib
  • Beijing, Beijing, China
    Lei Li
Apr 5, 2022

Targeted Therapy, Chemo, Recurrent Cervical Carcinoma Trial in Beijing (Donafenib combined with paclitaxel and platinum ± PD-1

Recruiting
  • Targeted Therapy
  • +6 more
  • Donafenib combined with paclitaxel and platinum ± PD-1 antibody
  • Beijing, Beijing, China
    Lei Li
Mar 26, 2022

Recurrent Cervical Carcinoma, Persistent Advanced Cervical Carcinoma, Chemo Trial in Beijing (Chemotherapy plus apatinib)

Completed
  • Recurrent Cervical Carcinoma
  • +5 more
  • Chemotherapy plus apatinib
  • Beijing, Beijing, China
    Lei Li
Mar 12, 2022

Gastrointestinal Cancer, Immunotherapy, Targeted Therapy Trial in Harbin (Camrelizumab, Apatinib Mesylate)

Recruiting
  • Gastrointestinal Cancer
  • +2 more
  • Harbin, Heilongjiang, China
    Harbin Medical University
Feb 4, 2022

HER-2 Positive Breast Cancer Patients at High Altitude

Not yet recruiting
  • HER2-positive Breast Cancer
  • +3 more
  • High altitude
  • Xining, Qinghai, China
    Affiliated Hospital of Qinghai University
Sep 30, 2021

Cholangiocarcinoma, Biliary Tract Cancer, Targeted Therapy Trial in Beijing (Lenvatinib)

Completed
  • Cholangiocarcinoma
  • +2 more
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Jun 2, 2021

Esophageal Cancer, Chemo Effect, Chemoradiation Trial in Beijing (drug, radiation, procedure)

Recruiting
  • Esophageal Cancer
  • +6 more
  • Platinum based chemotherapy
  • +6 more
  • Beijing, China
    Department of Radiation Oncology, National Cancer Center/Nationa
Mar 26, 2021

Lung Cancer, Targeted Therapy Trial in Worldwide (AZD9291)

Unknown status
  • Lung Cancer
  • Targeted Therapy
  • Copenhagen, Denmark
  • +6 more
Mar 4, 2020

Targeted Therapy, HER2, Biliary Tract Cancer Trial in Beijing (chemo in combination with trastuzumab for arm1, chemo in

Unknown status
  • Targeted Therapy
  • +4 more
  • chemotherapy in combination with trastuzumab for arm1
  • +3 more
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jul 17, 2019